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Microbial adhesion to biomaterial surfaces and subsequent biofilm formation 
has been observed on nearly all medical devices with severe economic and 
medical consequences. The significant resistance of biofilms to conventional 
antibiotic therapies has encouraged the development of new biomaterials 
and coatings. Biosurfactants represent an interesting approach as they can 
be used to modify the surface properties conferring it an anti-adhesive and 
antimicrobial activity, leading to new and effective means of combating 
colonization by pathogenic microorganisms without the use of synthetic 
drugs and chemicals. These microbial compounds constitute a diverse 
group of surface-active molecules occurring in a variety of chemical 
structures. Biosurfactants from lactic acid bacteria have been used as a 
strategy to avoid microbial colonization of silicone rubber voice prostheses. 
Also, they were found to be active against several bacteria and filamentous 
fungi responsible for diseases and infections in the urinary, vaginal and 
gastrointestinal tracts, and in the skin. Nevertheless, it is important to stress 
that the insufficient data on their toxicity for humans, as well as their high 
costs of large-scale production, have been restraining their 
commercialization and use in most medical applications. Many 
biotechnological strategies have been pursued to reduce the biosurfactants 
production costs including the use of agro-industrial wastes as substrates, 
optimization of medium and culture conditions, and efficient recovery 
processes. However, the improvements obtained from these strategies are 
marginal and to successfully compete with synthetic surfactants, novel 
microorganisms must be designed. The use of hyper-producer strains allows 
increasing the production yields and consequently reducing costs. These 
strains can be screened from the natural environment, or engineered using 
synthetic biology approaches. Hence, data on the genes involved on the 
production of biosurfactants is critical for designing organisms with improved 
features. Once the genes have been indentified and isolated, they can be 
expressed in other microorganisms, or they can be modified or placed under 
regulation of strong promoters to increase their expression and so enhance 
production. This knowledge will also allow the production of novel 
biosurfactants with specific new properties for different industrial 
applications. Further advances in genetic engineering of the known 
biosurfactant molecules could yield potent biosurfactants with altered 
antimicrobial profiles and decreased toxicity against mammalian cells.  
  
